{"id":"https://openalex.org/W7030470588","doi":null,"title":"A Model for Evaluating Pharmaceutical R&D Investment Projects under Technical and Economic Uncertainties","display_name":"A Model for Evaluating Pharmaceutical R&D Investment Projects under Technical and Economic Uncertainties","alternate_titles":[],"publication_year":2010,"publication_date":"2010-02-18","ids":{"openalex":"https://openalex.org/W7030470588"},"language":"en","primary_location":{"id":"pmh:oai:repub.eur.nl:18211","doi":null,"is_oa":true,"landing_page_url":"http://repub.eur.nl/pub/18211","pdf_url":"https://repub.eur.nl/pub/18211/ERS-2010-009-STR.pdf","source":{"id":"https://openalex.org/S4377196287","display_name":"RePub (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ERIM report series research in management Erasmus Research Institute of Management","raw_type":"info:eu-repo/semantics/workingPaper"},"parent_works":[],"lineage":["https://openalex.org/W7030470588"],"child_works_count":0,"type":"report","is_traditional":false,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://repub.eur.nl/pub/18211/ERS-2010-009-STR.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073075555","display_name":"Enrico Pennings","orcid":"https://orcid.org/0000-0003-1403-9857","observed_orcids":["https://orcid.org/0000-0003-1403-9857"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pennings, H.P.G. (Enrico)","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Sereno, L. (Luigi)","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sereno, L. (Luigi)","raw_affiliation_strings":["Department of Economics , University of Pisa Via Ridol\u2026 , 10 , 56124 , Pisa , Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Economics , University of Pisa Via Ridol\u2026 , 10 , 56124 , Pisa , Italy","institution_ids":["https://openalex.org/I108290504"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T11976","display_name":"Capital Investment and Risk Analysis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2003","display_name":"Finance"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11976","display_name":"Capital Investment and Risk Analysis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2003","display_name":"Finance"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10067","display_name":"Stochastic processes and financial applications","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2003","display_name":"Finance"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmaceutical-r-d-investment","display_name":"pharmaceutical R&D investment","score":0.925000011920929},{"id":"https://openalex.org/keywords/compound-options","display_name":"compound options","score":0.6990000009536743},{"id":"https://openalex.org/keywords/option-value","display_name":"option value","score":0.5899999737739563},{"id":"https://openalex.org/keywords/technological-uncertainty","display_name":"technological uncertainty","score":0.9660000205039978},{"id":"https://openalex.org/keywords/economic-uncertainty","display_name":"economic uncertainty","score":0.9789999723434448},{"id":"https://openalex.org/keywords/poisson-jump-process","display_name":"Poisson jump process","score":0.7770000100135803},{"id":"https://openalex.org/keywords/drug-development-failure","display_name":"drug development failure","score":0.7459999918937683},{"id":"https://openalex.org/keywords/abandonment","display_name":"abandonment","score":0.3799999952316284},{"id":"https://openalex.org/keywords/diffusion","display_name":"diffusion","score":0.7110000252723694},{"id":"https://openalex.org/keywords/sensitivity-analysis","display_name":"sensitivity analysis","score":0.5590000152587891}],"concepts":[{"id":"https://openalex.org/C144251240","wikidata":"https://www.wikidata.org/wiki/Q7068229","display_name":"Nucleofection","level":4,"score":0.4668000042438507},{"id":"https://openalex.org/C2992336715","wikidata":"https://www.wikidata.org/wiki/Q63431143","display_name":"Gestational period","level":4,"score":0.39399999380111694},{"id":"https://openalex.org/C2778283623","wikidata":"https://www.wikidata.org/wiki/Q18032200","display_name":"TSG101","level":5,"score":0.34880000352859497},{"id":"https://openalex.org/C2777054765","wikidata":"https://www.wikidata.org/wiki/Q6402731","display_name":"Dysgeusia","level":3,"score":0.33550000190734863},{"id":"https://openalex.org/C180938184","wikidata":"https://www.wikidata.org/wiki/Q2142270","display_name":"Liquation","level":3,"score":0.33399999141693115},{"id":"https://openalex.org/C18743360","wikidata":"https://www.wikidata.org/wiki/Q1208096","display_name":"Diafiltration","level":4,"score":0.33079999685287476},{"id":"https://openalex.org/C2777968768","wikidata":"https://www.wikidata.org/wiki/Q1280161","display_name":"Emperipolesis","level":4,"score":0.3215000033378601},{"id":"https://openalex.org/C2776781215","wikidata":"https://www.wikidata.org/wiki/Q83253","display_name":"Triacetin","level":2,"score":0.3183000087738037},{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.30320000648498535},{"id":"https://openalex.org/C133074676","wikidata":"https://www.wikidata.org/wiki/Q428729","display_name":"Fusible alloy","level":2,"score":0.30320000648498535},{"id":"https://openalex.org/C104545631","wikidata":"https://www.wikidata.org/wiki/Q464858","display_name":"Demotion","level":3,"score":0.30300000309944153},{"id":"https://openalex.org/C2777935831","wikidata":"https://www.wikidata.org/wiki/Q3144949","display_name":"Hemopericardium","level":3,"score":0.2969000041484833},{"id":"https://openalex.org/C145741570","wikidata":"https://www.wikidata.org/wiki/Q7251534","display_name":"Proteogenomics","level":5,"score":0.29580000042915344},{"id":"https://openalex.org/C2778843634","wikidata":"https://www.wikidata.org/wiki/Q2013780","display_name":"Ocrelizumab","level":4,"score":0.2955000102519989},{"id":"https://openalex.org/C135979968","wikidata":"https://www.wikidata.org/wiki/Q609809","display_name":"Protein isoform","level":5,"score":0.2903999984264374},{"id":"https://openalex.org/C2777158700","wikidata":"https://www.wikidata.org/wiki/Q1419356","display_name":"Hyporeflexia","level":3,"score":0.28600001335144043},{"id":"https://openalex.org/C2775917601","wikidata":"https://www.wikidata.org/wiki/Q1424050","display_name":"Sclerodactyly","level":4,"score":0.2818000018596649},{"id":"https://openalex.org/C2779645999","wikidata":"https://www.wikidata.org/wiki/Q1858477","display_name":"Frugality","level":2,"score":0.28119999170303345},{"id":"https://openalex.org/C2779627259","wikidata":"https://www.wikidata.org/wiki/Q779763","display_name":"Pretext","level":3,"score":0.2777999937534332},{"id":"https://openalex.org/C2909186138","wikidata":"https://www.wikidata.org/wiki/Q1500373","display_name":"Hyperlactatemia","level":2,"score":0.2734000086784363},{"id":"https://openalex.org/C2781032047","wikidata":"https://www.wikidata.org/wiki/Q938793","display_name":"Articular cartilage damage","level":5,"score":0.26989999413490295},{"id":"https://openalex.org/C2780904289","wikidata":"https://www.wikidata.org/wiki/Q426498","display_name":"Tantalum carbide","level":3,"score":0.2696000039577484},{"id":"https://openalex.org/C2776714567","wikidata":"https://www.wikidata.org/wiki/Q7861081","display_name":"Typhoid vaccine","level":3,"score":0.2623000144958496},{"id":"https://openalex.org/C2778128915","wikidata":"https://www.wikidata.org/wiki/Q3782613","display_name":"Contractualism","level":2,"score":0.2567000091075897},{"id":"https://openalex.org/C2776356786","wikidata":"https://www.wikidata.org/wiki/Q1048573","display_name":"Tubulopathy","level":3,"score":0.2538999915122986}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:repub.eur.nl:18211","doi":null,"is_oa":true,"landing_page_url":"http://repub.eur.nl/pub/18211","pdf_url":"https://repub.eur.nl/pub/18211/ERS-2010-009-STR.pdf","source":{"id":"https://openalex.org/S4377196287","display_name":"RePub (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ERIM report series research in management Erasmus Research Institute of Management","raw_type":"info:eu-repo/semantics/workingPaper"}],"best_oa_location":{"id":"pmh:oai:repub.eur.nl:18211","doi":null,"is_oa":true,"landing_page_url":"http://repub.eur.nl/pub/18211","pdf_url":"https://repub.eur.nl/pub/18211/ERS-2010-009-STR.pdf","source":{"id":"https://openalex.org/S4377196287","display_name":"RePub (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ERIM report series research in management Erasmus Research Institute of Management","raw_type":"info:eu-repo/semantics/workingPaper"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7030470588.pdf","grobid_xml":"https://content.openalex.org/works/W7030470588.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W51022820","https://openalex.org/W1981291749","https://openalex.org/W1990664633","https://openalex.org/W2015497339","https://openalex.org/W2018921332","https://openalex.org/W2022202554","https://openalex.org/W2029342376","https://openalex.org/W2055759661","https://openalex.org/W2068496814","https://openalex.org/W2077791698","https://openalex.org/W2120146090","https://openalex.org/W2131007479","https://openalex.org/W2151065060","https://openalex.org/W2158765829","https://openalex.org/W3122982963"],"related_works":["https://openalex.org/W2029037539","https://openalex.org/W1971747955","https://openalex.org/W2274778783","https://openalex.org/W3043415434","https://openalex.org/W2559672012","https://openalex.org/W1977566621","https://openalex.org/W7065308451","https://openalex.org/W2049884150","https://openalex.org/W7028276051","https://openalex.org/W2429252083"],"abstract_inverted_index":{"This":[0],"study":[1],"sets":[2],"up":[3],"a":[4,27,46,64,73],"compound":[5],"option":[6,79,93],"approach":[7],"for":[8,32],"evaluating":[9],"pharmaceutical":[10],"R&D":[11,78],"investment":[12],"projects":[13],"in":[14],"the":[15,38,77,83,89,92],"presence":[16],"of":[17,37,58,91],"technical":[18,105],"and":[19,34,99],"economic":[20,97],"uncertainties.":[21],"Technical":[22],"uncertainty":[23,42,98,106],"is":[24,43,61],"modeled":[25,44],"as":[26,45],"Poisson":[28],"jump":[29],"that":[30,69,88],"allows":[31],"failure":[33],"thus":[35],"abandonment":[36],"drug":[39],"development.":[40],"Economic":[41],"standard":[47],"di\u00a4usion":[48],"process":[49],"which":[50],"incorporates":[51],"both":[52,70],"up-and":[53],"downward":[54],"shocks.":[55],"Practical":[56],"application":[57],"this":[59],"method":[60],"emphasized":[62],"through":[63],"case":[65],"analysis.":[66],"We":[67],"show":[68],"uncertainties":[71],"have":[72],"positive":[74],"impact":[75],"on":[76],"value.":[80],"Moreover,":[81],"from":[82],"sensitivity":[84,90],"analysis,":[85],"we":[86],"nd":[87],"with":[94],"respect":[95],"to":[96],"market":[100],"introduction":[101],"cost":[102],"decreases":[103],"when":[104],"increases.":[107]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7030470588","counts_by_year":[],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2025-10-10T00:00:00"}
